Treatment Considerations for Patients With Neuropathic Pain and Other Medical Comorbidities
- Recommendations for the Pharmacological Management of Neuropathic Pain: An Overview and Literature Update. Dworkin, Robert H.; O'Connor, Alec B.; Audette, Joseph; Baron, Ralf; Gourlay, Geoffrey K.; Haanpaa, Maija L.; Kent, Joel L.; Krane, Elliot J.; Lebel, Alyssa A.; Levy, Robert M.; Mackey, Sean C.; Mayer, John; Miaskowski, Christine; Raja, Srinivasa N.; Rice, Andrew S. C.; Schmader, Kenneth E.; Stacey, Brett; Stanos, Steven; Treede, Rolf-Detlef; Turk, Dennis C. // Mayo Clinic Proceedings;Mar2010 Supplement, Vol. 85, pS3
The Neuropathic Pain Special Interest Group of the international Association for the Study of Pain recently sponsored the development of evidence-based guidelines for the pharmacological treatment of neuropathic pain. Tricyciic antidepressants, duai reuptake inhibitors of serotonin and...
- Duloxetine/pethidine interaction. // Reactions Weekly;3/19/2011, Issue 1343, p16
The article describes a case of serotonin syndrome which developed in a 52-year-old woman following pethidine administration two days after discontinuing duloxetine.
- Clinically Significant Drug Interactions with Newer Antidepressants. Spina, Edoardo; Trifirô, Gianluca; Caraci, Filippo // CNS Drugs;2012, Vol. 26 Issue 1, p39
After the introduction of selective serotonin reuptake inhibitors (SSRIs), other newer antidepressants with different mechanisms of action have been introduced in clinical practice. Because antidepressants are commonly prescribed in combination with other medications used to treat co-morbid...
- Placenta hydrolysate/serotonin uptake inhibitors. // Reactions Weekly;6/14/2012, Issue 1410, p33
The article describes the case of a 44-year-old female patient who developed reversible cerebral vasoconstriction syndrome while receiving treatment with placenta hydrolysate and selective serotonin reuptake inhibitors.
- Bupropion/citalopram/lamotrigine/trazodone interaction. // Reactions Weekly;Apr2014, Vol. 1495 Issue 1, p12
The article presents a case study of a 57-year-old man who developed acute dystonic reaction while receiving treatment with bupropion, citalopram, lamotrigine and trazodone.
- Metabolic Drug Interactions Between Antidepressants and Anticancer Drugs: Focus on Selective Serotonin Reuptake Inhibitors and Hypericum Extract. Caraci, Filippo; Crupi, Rosalia; Drago, Filippo; Spina, Edoardo // Current Drug Metabolism;Jul2011, Vol. 12 Issue 6, p570
No abstract available.
- Selective Serotonin Reuptake Inhibitors and Cytochrome P-450 Mediated Drug-Drug Interactions: An Update. Hemeryck, Alex; Belpaire, Frans M. // Current Drug Metabolism;Feb2002, Vol. 3 Issue 1, p13
The selective serotonin reuptake inhibitors (SSRIs) have become the most prescribed antidepressants in many countries. Although the SSRIs share a common mechanism of action, they differ substantially in their chemical structure, metabolism, and pharmacokinetics. Perhaps the most important...
- Ischaemic optic neuropathy: 5 case reports. // Reactions Weekly;5/7/2016, Vol. 1600 Issue 1, p190
An abstract of the article "SSRI-associated optic neuropathy" by M.L. Moster and others is presented.
- Who Develops Severe or Fatal Adverse Drug Reactions to Selective Serotonin Reuptake Inhibitors? Dalfen, Ariel K; Stewart, Donna E // Canadian Journal of Psychiatry;Apr2001, Vol. 46 Issue 3, p258
Objective: To ascertain the risk factors associated with the development of severe and fatal adverse drug reactions (ADRs) or intentional overdoses by patients on selective serotonin reuptake inhibitors (SSRIs). Methods: We undertook a data analysis of Health Canada's database of 'Adverse Drug...